Reprints of Past Articles
Choose a Reprint by Title Choose letter:
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y |
A…
- The Absolute, Relative, and Incremental ROI of DTC e-Marketing
- Accomplishing Adherence
- Accountability for Pharma Content on Social Media Sites
- A Call to Action: A Mea Non Culpa by Big Pharma
- Active Social Media Listening
- Ad Dollars Follow Eyeballs to Web
- Ad Execs Not Viewed as Innovative By Americans Says AstraZeneca Survey
- Adherence: Do We Really Need an App for That?
- Adobe Connect for eDetailing
- Adverse Event Reporting: A Missed Opportunity
- A Few Things I Learned at FDA’s Social Media Hearing
- A Good Time Was Had by All
- Americans Skeptical of Pharma Cause Marketing
- Anecdotal Experience Marketing
- An Online Community to Call Our Own
- Antidepressants: Top Advertised & 3rd Most Commonly Used Rx Drug
- Anti-DTC Resurgence
- Applying FDA Marketing Regulations to Internet Promotions
- Are Pharma Bloggers Biased Against the Industry?
- Are Drug.com Websites “Fair and Balanced?”
- Are Pharma Reps Important to Docs or Not?
- Are Pharma Sales Reps Service Employees?
- Are Sales Reps as “Useful” as PhRMA Wants Us to Believe?
- Are Sales Reps Necessary?
- Are Some DTC Print Ads Too Educational and/or Persuasive?
- AstraZeneca Hosts First-Ever Twitter Chat
- Awards. What Are They Good For?
B…
- Bad, Devalued, Distrusted & Defensive Pharma
- Balancing Idealistic vs. Realistic CRM Processes
- 2014: A Banging Year for Drug Approvals, A Wimpy Year for Enforcement
- Betting the Pharm
- Beyond DTC: Consumer Relationship Satisfaction
- Beyond Patient Education: Influencing Behavior Change
- Beyond the eDetail: Evolving to Educate
- Big Bad Pharma
- The Big C in the Big Apple
- Big Pharma Sales Analytics for the Rest of Us
- Biotech DTC: Business Not As Usual
- BI Receives Pharmaguy Social Media Pioneer Award
- Blogging My Way Into 2005!
- Blogs and the Pharmaceutical Industry
- Boehringer vs Facebook Social Media Socialism
- Branded Physician Education: How to Integrate Promotion and Education
- Branding Internally: Think Brand, Not Product
- The Brand Marketing Mix
- Brave New World of Off-Label Marketing
- Breaking the 140-character Limit of Twitter
- British Pharma Digital Update
- The British Pharmaceutical Industry Issues Social Media Guidance for Adverse Event Reporting
- Brits Beat FDA & PhRMA: Issue Social Media Guidance for Pharma
- Building a Blockbuster
- Building the “New” Pharma Physician Marketing Model
- Building the Optimal Service Model: Creating the Right Physician Experiences to Drive Business
- Building Power Sales Messages
- Buzz ‘n Blog Marketing
C…
- California’s Physician Prescribing Act: A History of Twists and Turns
- Can Health Web Sites Improve Compliance?
- Capturing & Reporting HCP-Related Meeting Spending
- cDetailing: Addressing the Consumer Education Gap
- Celebrities + Social Media
- Certain Physician-Drug Industry Relationships Have Declined Dramatically
- Challenges of Regulating Mobile Medical Apps
- The Changing Pharma Commercial Model in 2010 and Beyond
- The Changing Pharma eDetailing Landscape
- The Changing Landscape of Physician Interactions
- The Changing Policy Landscape: Prepare Now for the Coming FDA and Pharmaceutical Marketing Reforms
- The Changing Role of Pharma Sales Reps
- The Changing World of MSLs: Determining Value
- Checking Under the Hood of Pharma Mobile Apps
- Cholesterol Drug Users Discuss Their Medication
- Citizen Petition Likely to Delay FDA Social Media Guidance
- Closed Loop Marketing
- Closed-Loop Patient Education
- Collaborating with Online Physician Communities
- The Comeback of CME without Pharma
- The Coming Pharma Digital Depression
- The Coming Pharma Marketing Recession
- Communicating Risk: Let the Dialog Begin
- Compliance with (Some) New ACCME Rules Not So Easy
- Congress vs. Pharma: Trouble Ahead?
- Consequences of Direct-to-Consumer Advertising
- Consequences of eDetailing Technology
- The Consumer Brief Summary: FDA’s New Thinking Regarding Risk Communication
- Consumer Use of the Internet for Health: Whose Numbers Do You Believe?
- Controlling Your Brand’s Switch Destiny
- Corporate Reputation in the New Media World
- Corporate “Moral Values” Anyone?
- Cost-Cutting Strategies for the Pharma Industry
- Could Chill Kill CME?
- Creating a Successful DTC Campaign on the Inside
- Creating the Most Effective Sales Calls
- A Crisis in Professional Detailing
- Critical: What Daschle Plans to Do About the Healthcare Crisis
- Crowd Sourced Creative Commons Drug Information
- Current Issues and Future Prospects for Sales Force Effectiveness
- Cute & Creepy DTC Drug Ad Mascots
D…
- Data Mining in the Deep, Dark Social Networks of Patients
- Deal with Lack of Regulations by Developing Best Practices (pdf)
- Deconstructing Pitts’ Guiding Principles for Pharma Social Media
- The Debut of the Chief Patient Officer: A Passing Fad or Transformative?
- Developing Guidelines for Pharma’s Use of the Internet & Social Media: A Call for a Public Hearing at FDA
- Developing Win-Win Key Opinion Leader Relationships
- The Digital Life of Doctors
- The Digital Health Coalition
- Digital Pharma Is Alive and Well in Europe!/A>
- Digitally-Feeble Pharma
- Digitally Savvy Women Pharma Pioneers
- Direct to Physician Telemarketing and Sales
- Disease Mongering
- Disease Mongering: When Is the Line Crossed?
- Diversity in the Life Sciences
- Diversity in Pharma
- Do Drug Copay Coupons Drive Up Healthcare Costs?
- DocCheck: Das Portal
- Does the FDA Need to be Overhauled?
- Doing a Good Job but Still Not Trusted!
- Do TV DTC Ads Overstate Rx Drug Risks?
- Double Dip in DTC Ad Spend!
- Drug Industry v. FDA Re: Twitter & Google Adwords
- Drug Reimportation Survey Results
- Drug Marketers Need More Than Demographic Data To Effectively Market To Consumers
- Drug Prices, Declining Profits Top Issues for 2005
- Drug Risk Survey Results
- DTC Ad Spending Rises From the Grave: Pfizer Leads the Ghoulish Pack
- DTC, for Better or Worse, is Here to Stay
- DTC in 2005: Can You Teach Old Dogs New Tricks?
- DTC Promotion Directed at Adolescents
- DTC Pros and Cons Presented at FDA Hearing
- DTC Risk Communication
- DTC User Fees Go PDUffft!
E…
- eDetailing: Yesterday, Today and Tomorrow
- The End of DTC as We Have Known It
- E-mail Marketing Best Practices for Pharma
- Emotions, Focus and Storytelling: How Cialis is Challenging Viagra
- e-Marketing at the Point of Care
- Effective Pharma Adherence Programs Start With The Patient
- Effective Physician Marketing at Medical Meeting Exhibits
- e-Inertia Plagues the Pharma Industry
- The Empowered Patient: What It Means for Pharma Marketers
- The ePharma Pioneer Club™: Convincing Pharma Marketers to Engage in “e”
- ePrints NRx for Physician Detailing
- The Electronic Formulary Will Change the Equation
- The Emerging Virtual Medical Conference
- Engagement
- Ethical Online Practices Build Consumer Trust
- European Compliance Not Only Possible, But Leading Edge
- The European eMarketing Scene: Desperately Seeking Strategy
- European Online Marketing Survey Results
- Evaluating DTC TV Drug Ads
- Everything You Need to Know About Mobile Platforms
- Evidence-Based Pharma Marketing
- Evolve Your Brand into a Relationship with Consumers and Physicians
- The Evolving Impact of Anti-Spam Legislation on Online Marketers
- The Evolving Pharma-Physician Relationship
- The Expanding Pharma Blogosphere
- Exploring the 2.0 Doctor-Patient Relationship
- Eyes on the Adherence Prize/A>
F…
- Facilitating Physician Access and Education Through Online Conferencing
- Fair Social Media Practice Principles
- Fast Start to Customized ePromotion and eLearning Physician Programs
- FDA Can Relax. I Did All the Work for Them!
- FDA Draft Guidance for Print DTCA: Less than Feared
- FDA Draft Guidance on Risk
- FDA Drops Social Media from Its Guidance Agenda
- FDA Finalizes Guidance on Distribution of Reprints
- FDA Guidance: Responding to Unsolicited Requests for Off-Label Information
- FDA Issues Long-Awaited Guidance for Mobile Medical Apps
- FDA’s Abrams Spends 4 Minutes on Social Media!
- FDA’s Good Reprint Practices Guidance
- FDA Opens Window for Pharma to Correct Misinformation Online
- FDA Publishes First Piece of Long-Awaited Social Media Guidance
- FDA Sets Up a Roadblock for Branded Rx Promotional Tweets
- FDA’s Use of Social Media: Peanuts Today, Drugs Tomorrow!
- FDA to Test New Standard for Easy to Understand Drug Labels
- FDA v. Google & Those 14 Infamous Warning Letters
- FDA Social Media Guidelines May Be Moot
- Fear and Loathing in Washington, DC
- Finding the Consumer Within the Patient
- Finding the “Right Stuff” to Revitalize Sales Productivity
- First FDA Social Media Guidance to Address Responding to “Unsolicited Requests” for Off-label Information
- Focus on Drug Safety Communication & TV DTC Advertising
- A Formula for Patient-Centric mHealth Apps
- Four Useful Lessons Pharma Can Learn from the Pfizer Facebook Hack
- Free Drug Samples: The Sales Rep’s Last Great Hope?
- Free Gifts to Physicians: What’s the Big Deal?
- Free Prescription Drug Cards
- From Nalty to “Nalts”: The Transformation of a Pharma Marketing Director into a “Viral Video Genius”
- From Science to CEO: The Scientific Path to Corporate Leadership
- The FTC-Lilly Consent Decree: What it Means for PHARMA Vendors and Partners
- The Future of Big Pharma
- The Future of DTC Advertising: Is a Perfect Storm Brewing?
- The Future of eDetailing
- The Future of Pharma Marketing is Mobile, Unless …
G…
- Gamification
- Generation Rx: A History and Critique of Pharma “Tribal Marketing”
- Get Social, #GetFit and Get Healthy
- Getting Market Research Right in Emerging Markets
- Getting Market Research Right in India & China
- Getting Market Research Right in the Middle East/A>
- Give Docs What They Want
- Global Digital Asset Brand Management
- Global Pharma Competitive Intelligence
- God Bless R&D, but Marketers May Go to Hell!
- Good Promotion Practices Alliance
- Google’s OneBox Drug “Ads” Steal Clicks Away from Rx Brands
- Got Game? Online Pharma Advergaming
- Growing Pharmaceutical Sales Utilizing Six Sigma and Lean
- GSK’s U.S. Sales Reps “Europeanized”
- GSK Strikes Back with a Grassroots Campaign
- Guerilla Pharma Marketing
- Guidelines for Off-label Communications
H…
- Hard Sell: The Evolution of a Generation X Salesman
- Has DTC Spending Peaked?
- HCP Marketing Beyond the Physician: Plugging Into NPs and PAs
- Healthcare Communications vs. Pharma Marketing (pdf)
- Help Doctors Educate Patients About Their Condition & Treatment
- Helping Pharma eMarketing “Grow up”
- HealthPrize Teams Up with RealAge to Improve Adherence
- Here Come the Pharma Wikipedians
- High Impact Content in Support of Rx Brands
- How is the iPad an Effective Delivery Platform for Medical Sales Professionals?
- How Readable, Credible & Useful are Pharma Blogs?
- How to Achieve Digital Pharma Marketing Results
- How to Get Your Message In Front of Pharma Brand Managers
- How to Host a Successful Pharma TweetChat
- How to Manage the Online Conversation
- How to Score With Women (as a Marketer) via Social Media
- How to Sell a Drug Before it is Approved
- How Should Pharma Engage in Social Networks?: Thoughts on Best Practices
- The Hypocrisy of Healthcare Marketing Restrictions: Stand Up for Healthcare Marketing Free Speech
I…
- I’m All a Twitter Over Twitter
- The Impact of eDetailing: Will it Complement, Replace, or Become Integrated with the Sales Force?
- Implications of Facebook’s Page Commenting Changes
- Increase Prescription Sales with Smart Tools
- India’s Booming Pharmaceutical Market
- Industry and Consumer Advocates Square Off Regarding Social Media
- In Memory of Steve Jobs Will Novartis Sales Reps Really Embrace iPads?
- Innerstate: The First Disease Awareness Documentary Film
- Integrating Compliance into Commercial Practices
- Integrating Online & Offline Marketing: Challenges for Pharma
- Integration of Custom Media into the Marketing Mix
- Intelligent Online Sampling Strategies
- The Internet and CME
- Interpretation of Ads
- The iPad as a Pharma Marketing Platform
- The iPad in the Doctor’s Office
- Is It Time to End Industry Sponsored CME?
- Is Online Pharma Advertising ROI Scalable?
- Is Pharma Ready for HIPAA?
- Is Pharma Marketing a Lot of BS?
- Is Your Marketing Head in the Cloud?
- Is Your Product Ready for Consumers?
- It’s All About Education
- It’s the Science, Stupid!
- Is There a Cure for Mediocre Pharma Mobile Apps?
- Is There an Upward Career Path for Pharma Social Media Pioneers?
J…
K…
- Key Issues Facing DTC Marketers in 2004
- A KOL by Any Other Name: Too Toxic for Everyday Use, or Still the Best Term to Use?
L…
- Let’s Respond to FDA’s Questions Regarding Its Regulation of Social Media
- Leverage Health Beliefs to Develop Effective Online Compliance Programs
- Leveraging Infographics and Search for Better Health Communications
- Leveraging Multi-Channel Infographics for Patient Support
- Limbic Market Research: Plumbing the Subconscious Motivators of Physicians
- Limiting Bias in Commercially Supported CME
- Lipitor Holds Key to DTC Ad Spending in 2012
M…
- Making Sense of Multichannel Marketing
- Managing Cross Boundary Issues
- Managing Medical Science Liaisons From Afar
- Managing Privacy Risks in Your Commercial Practices
- Managing Reprints for Better Clinical Support of Marketing
- Mapping New Paths through the DTC Marketing Mix Maze
- Marketing in the Post-Vioxx Era
- Marketing the Pharma Industry: The Empire Strikes Back
- Marketing’s Role in Limiting Physician Access and What to Do About It
- Maximizing the DTC Message: Healthcare Businesswomen’s Association Members Evaluate DTC Marketing
- Measuring an Intangible: Medical Science Liaison Metrics Consensus
- Measuring & Communicating eSuccess: Strategy First, YouTube Later… Maybe
- Measuring Marketing Strategy
- Measuring Consumer Sentiment About Prescription Drugs
- Medical Device Marketing
- Medical Science Liaisons: Working between Two Worlds
- Medical Transcript Advertising
- Merit of CHC Petition to FDA
- Merck Rejiggers Its Marketing Mix
- Midwestern eMarketing Values
- Mining Mobile Health App User Data
- Mobile Apps Track Sunshine Payments
- The Mobile Health Library™
- Mobile Medical App Guidance & Beyond!
- Mobile Medical Reference: An Effective Door Opener for Sales Reps
- Mobile Optimization Offers Better ROI Than Mobile Apps
- Mobile Pharma Marketing: What’s the 411?
- Mobile Regulatory Fears: PhRMA Raises an Alarm
- Moderation Best Practices for Pharma Social Networks
- Moore: Please Don’t Ignore Us Pharma Bloggers
- Most Credible Bad Ad Complaints are Submitted by Pharma
- Motivating & Retaining The MSL: What Makes MSLs Tick
- Moving the Needle on Adherence
- MSL Role in Educational Development
- MSL Roles & Goals
- Multichannel Marketing & Medical Reprints
- Multichannel Marketing
- Murky Physician Marketing and Education Practices
N…
- New Big Pharma Economies of Scale
- A New Estimate of Drug Development Cost
- New Facebook Policy “Kind of Hurts” Pharma Marketers
- New Media Privacy Issues & Online Health Marketing
- The New PhRMA Code and Beyond: Federal & State Laws are Eclipsing Self-Regulation
- New Privacy Rules in Economic Stimulus Law: Will They Restrict Certain Pharmaceutical Marketing Practices?
- The New Rules of Marketing & PR: Book Review and Insights for Pharma
- New Social Media Regulatory Framework
- The New Written Prescription: Leveraging Technology to Measure Change in Physician Behavior as it Occurs
- 2015 New Year’s Resolutions
- The Next FDA Commissioner Will Be…
- No More Free Lunch in California?
- A Novel Approach to Communicating with Physicians
- Novo Nordisk Defends Choice of Paula Deen as Diabetes Spokesperson
- Numbers
O…
- Obama v. McCain Survey Results
- One…uh, Two Small Steps for Pharmaco Blogging!
- Online and Offline Professional and Consumer Marketing
- Online CME – A Glass Half-Full or Half-Empty?
- Optimizing Brand Equity: Pre-Launch through Patent Expiry and Beyond!
- Optimizing Market Access: A Guide to Effective Pricing, Reimbursement and Messaging Strategies
- Optimizing DTC Performance
- Optimizing eDetailing ROI
- Orphan Drugs Now “Where the Money Is,” Says Willie Sutton’s Ghost
- Out-of-the-Box Marketing: Will It Work for Pharma?
- Overcoming Space Limitations in Social Media
- Owning the Prescription Pad: Driving Brand Decisions in a Multi-Influence World
P…
- Paid Inclusion: Too Hot for Pharma Marketing?
- Patient Activists Demand Higher Quality Mobile Health Apps
- Patient Assistance Program Rankings: Going Beyond Sales Force Effectiveness to Customer Experience Satisfaction
- Patient Centricity, Transparency, & Pharma’s Reputation: Getting Beyond Lip Service
- Patient-Level Data: A New Level of Analysis
- Patient Detailing at the Point of Care
- Patient Storytelling Marketing
- The Patients Included Initiative & Pharma
- Personalized e-Marketing – How can you create and profit from a customer’s lifetime experience?
- Peter Rost: Whistle Blower, Pharma Blogger, ???
- Pfizer Battles to Protect Lipitor Cash Cow
- Pfizer France: Viva la SFE Difference!
- Pfizer’s Chapstick Slapstick Facebook Fiasco
- FREE! Pfizer’s SamplesDirect eSampling Program
- Pfizer’s Short-lived LIPITOR Branded Mobile App
- Pfizer, Show Us Your Social Media “Playbook”
- Pfizer Throws in the Lipitor Marketing Towel
- Pharma Begins to Reveal Payments to Physicians
- Pharma BloggoSphere Update
- Pharma C-Suite Social Media Dummies
- Pharma Collaboration with Online Patient Opinion Leaders
- Pharma Content Marketing Strategies
- Pharma Brand Personality Traits
- Pharma Crisis Communications in the Fast-paced World of Twitter et al
- Pharma eMarketing: A Level Playing Field or a Killing Field?
- Pharma Facebook Pages Being Phased Out: A Good Run While It Lasted!
- Pharma Finds Little to Like in Recent FDA Social Media Guidance
- Pharma is Overcoming Social Media Hurdles
- Pharma Marketers Dive Deeper Into Social Media: The Good, the Bad, & the Ugly Case Studies
- Pharma Marketing Blog a “Must Read”
- Pharma Marketing Buzzwords
- Pharma Marketing Ethics & Corporate Reputation Compendium
- Pharma Marketing Network 2007 Report
- Pharma Marketing Network Survey Results
- Pharma Marketing Stuck in Web 1.5
- Pharma Marketing Roundtable – Members Only!
- Pharma McCarthyism
- Pharma Online Spending
- Pharma Paid Celebrity Best Practices
- Pharma, Physicians, and Sermo
- PharmaPhobia & What to Do About It
- Pharma Promotional Spending in 2013
- Pharma Responds to FDA’s Draft DTC Guidelines
- Pharma SmartPhone/Tablet Apps: Is There a Regulation for That?
- A Pharma Social Media Conspiracy Theory: FDA, DOJ vs. Google
- Pharma and Social Media – Comfy Bedfellows
- Pharma-Sponsored Medical Ghostwriting: What the Ghosts Have to Say About It
- Pharma TeleWeb e-Detailing
- Pharma Trends to Watch in 2006
- Pharma Turns Up Heat to Unchill Off-Label “Free Speech”
- Pharma Twitter Pioneers Recognized
- Pharma YouTube Patient Videos Lack Transparency
- Pharma’s 2010 Christmas Wish List for Santa
- Pharma’s Bad Rep or Bad Rap: Whatever! The Drug Industry Must Earn Back the Public’s Trust
- Pharma’s Black Knight Confesses All!
- Pharma’s Confidence Crisis: A Call for a New Marketing Paradigm?
- Pharma’s Digital Media Adoption Curve
- Pharma’s Image Conundrum: Building Brand Loyalty and Consumer Confidence
- Pharma’s Physician Bailout
- Pharma’s Plodding Approach to eMarketing
- Pharma’s Social Media Marketing Readiness Score
- Pharma’s Social Media Working Group
- Pharma’s Use of Medical Conference Twitter Hashtags
- Pharmaceutical Competitive Intelligence
- Pharmaceutical Compliance with Fair Information Practice Principles
- Pharmaceutical Market Access 2010: Strategic Developments Impacting the US, EU, and Emerging Markets
- Pharmaceutical Marketing in Texas: look out for state privacy laws!
- The Pharmaguy Next Door
- Pharmaguy’s Pharma Predictions
- Pharmaguy’s Social Media Compendium
- The Pharmaguy Social Media Timeline™: Volume 1
- The Pharmaguy Social Media Timeline™: Volume 2
- Pharmaguy’s Twitter Followers: What Do They Want and How Is It Relevant to You?
- Pharmacy TeleStocking
- The Phil Mickelson Enbrel Campaign
- PhRMA Code Helps Re-define Roles of Medical Affairs and Marketing
- PhRMA Code Succeeding So Far
- PhRMA Masters the Art of “Proofiness!”
- PhRMA’s New Code on Interactions with Healthcare Professionals
- PhRMA Tells FDA How It Wants to Correct “Misinformation”
- Physician Adoption and Use of Technology at the Point of Care
- Physicians Favor Brands With a Compelling Adherence Program
- Physician-Generated Content on Social Media Sites
- Physician Meetings: Education Works Both Ways
- Physician Participation in Peer-to-Peer Social Media Sites
- Physicians Are Concerned That Pharma Supported CME is Biased, But …
- Physicians Under Pharma’s Influence
- Physician Value Index™
- Politics Vs. Science in the Plan B Decision
- The Power of Patient Input
- The Pozen Digital Advisory Board
- PR: Advertising by Other Means
- PR & Interactive Agencies Vie for Pharma Social Media Campaign Crumbs
- Predicting the Future of the Drug Industry
- Predictive Physician Marketing
- Prepare or Die!
- Prescription Drugs and the Health 2.0 Opportunity
- Presenting “New Risk Information” About Drugs to HCPs
- The Price of Drugs
- A Primer on Pharma Employee Blogging
- Print DTC: How Does It Measure Up?
- Proactive e-Marketing Plan
- Product Branding, e-Marketing May Be Underutilized
- Product Web Sites: Are They Worth It?
- A Proposal for a Drug Risk Advisory System
- Proposed Rules for Physician Payment Sunshine Act
- Protecting Your Brand with Anti-Counterfeiting Solutions
- Protection from Brand Infection: Marketers Must Take Control of Their Brands, Especially Online
- Provider/Pharmaceutical Partnerships – Are They Possible Without Conflict of Interest?
- Pushing the Envelope is Bad for DTC
- Putting the Customer Back in Customer Relationship Management
Q…
R…
- Ramifications of FDA Regulatory Actions: Helping FDA Find a New Media Regulatory Pathway
- Re-Designing the Pharma Sales Force
- Real Patient Testimonials
- Real Patients Star in Pharma Youtube Videos
- Redeemed “Sinners” as Pharma Spokespeople
- Reforming the FDA: It All Starts with a New Commissioner!
- Reigning in the “Wild West” of Mobile Health Apps
- Reinventing the Sales Model
- Relationship Marketing via eNutrition
- Relationship Marketing Program Management for Pharmaceutical Marketers
- Relationships
- Rep Access Programs
- Report from the Social Pharmer “Unconference”: Sowing Seeds of Social Media Change?
- Reporting Gifts to Physicians
- Responding to the Challenges of Evolving Regulation
- Restrict DTC, but Extend the Patent for New Drugs
- Results from FDA Physician Survey on DTC Advertising
- Return on CME: Are Pharma Companies Getting Desired Outcomes?
- The Revitalized Brand: Creating a New Brand Image from an Old Product
- Risk Mitigation and Its Impact on Pharma Marketing: Appropriate Use Benefits After Launch
- Right & Wrong Ways for Pharma to Correct Misinformation on Wikipedia
- The Role of Tablet PCs in Pharma Sales and Marketing
S…
- Sales Effectiveness Meets eMarketing
- Sales Force Effectiveness Metrics: More Important Than Ever in a Tough Market
- Sales Rep Assessment: Shoot the Messenger, the Message, or Both?
- Sales Reps Debate Their Value
- Sanofi Launches Diabetapedia
- Sanofi US Diabetes Team Wins 3rd Annual Pharmaguy Social Media Pioneer Award
- Scenarios on the Future of Pharma Marketing: No Time Like the Present to Think the Unthinkable
- Search Advertising Options for Pharma
- Searching for Answers on Search Engine Marketing?
- Separation of Church and State
- Self-Regulation as a Collective Blocking Strategy
- Should Bloggers Dine at Pharma’s Table?
- SiCKO is Boffo but Not Anti-Pharmaco Per Se
- Slides: The Currency of Communication
- Social Communications in Healthcare: Summary of Roundtable Discussions
- Social Media Adverse Event Reporting Safe Harbors: It’s Time for FDA to Open Up the Internet to Rx Advertising Like It Did with TV!
- Social Media and the Limitations of Disease Awareness Campaigns
- Social Media–Opportunity or Nightmare?
- Social Media & the Truncated News Pyramid
- Social Media Leaders Wanted
- Social Media, Latent Spokespersons & Native Advertising
- Social Network Marketing: The Wisdom of the Crowd
- The Socialisation of the Internet is Bogus
- Socially Challenged Pharma: How Ready is Pharma to Engage In Social Media?>
- Society of Industry Leaders: Help for Investors
- Up Front: Solving the Adherence Problem in Economic Hard Times
- Solving the Social Media Adverse Event Reporting Problem
- Some Unregulated Physician Smartphone Apps May Be Buggy
- The Sorry State of Pharma Mobile Health Apps
- Spam spam spam spam. Lovely spam! Wonderful spam!
- Spending on Direct-to-Consumer Advertising Takes a Nosedive
- Stakeholder Effectiveness
- Strategies for Marketing Compliance
- The State of CME in Europe
- Stop Wasting $Millions on Ineffective DTC Ads!
- Straight-Talking DTC Survey Results
- A Strategic Approach to CME Offers High Return on Education Investment
- Strategies for Enhanced Physician Targeting and Segmentation
- Strategies for Overcoming the Internal Challenges between Rx and OTC
- Super Bowl DTC Debut: Was It Good for You?
- Supporting Patients via Twitter and Beyond
- Surfing the eMarketing Big One!
- Surveys Say…
- Surviving the Election Wars
- Up Front: Syndication is da Bomb!
T…
- Tailoring CRM Solutions to Your Business Strategy
- A Tale of Two Pharma Whistleblower Novels
- Targeted Faith-based Disease Awareness Marketing
- The Targeted Model: The Future of Pharmaceutical Marketing?
- Teaching New Dogs Old Tricks
- Texas Medical Privacy Act: A Wolf in Sheep’s Clothing?
- Thought-Leader Management: A Challenge Met
- Times They Are A-Changing?
- Tips for Improving Pharma Sales
- To Ban or Not to Ban DTC, That is the Question
- To Build Patient Adherence, Pfizer Puts Technology Behind The Curtain
- Top Companies, Classes, and Products in the DTC Space
- Toward Patient-Centric Marketing — Working Effectively with Patient Groups
- Tracking Public Health Trends: Twitter vs Google vs Your Nose
- The Truth About the Drug Companies: What To Do About It
- Translate Industry Trends into the Optimal Promotional Strategy
- Transparency is the Word These Days
- Trends in Commercial Support of CME
- “Tribal Marketing”
- Turning Science into Sales
- TV DTC Advertising Is Not Dead Yet!
- The Twelve Steps of Pharma Social Marketers Anonymous
- 2015 Was a Golden Year for Pharma
- 2016 New Year’s Resolutions for Pharma
U…
- Understanding Drivers of Patient Behavior to Maximize DTC Effectiveness
- Understanding the Proposed ACCME Standards for Commercial Support
- Understanding the Strategic Value of MSLs
- US Drug Shortage & Supply Chain Crisis
- Use of Behavioral Targeting by Pharma Marketers
- Use of Celebrities for PR and DTC Advertising
- Use of Social Media for Health Purposes in the EU
- Use of Twitter for Patient Support
V…
- Value-based Pricing
- Vast Majority of Drug Ads in Leading Medical Journals Don’t Pass MDs’ Sniff Test!
- The View From ePharma Summit: Practicing What Was Being Preached!
- Vioxx Withdrawal and the “Me-Too Drug Domino Effect”
- The Virtual Sales Rep
W…
- Waiting for Goduidance (pdf)
- Waning Pharma Support of CME: The Plight of For-Profit MECCs
- Want to Know What Really Sucks?
- Wearables, Ingestibles, Implantables
- A Web-based Therapy Management Program
- Web 2.0 Pharma Marketing Tricks for Dummies
- What Americans Think About Drug Advertising
- What Do Physicians Think About DTC, ePromotion, and Social Media?
- What If There Were No Rules in Pharma Marketing?
- What Pharma Companies Spend on Gifts to Docs
- What Stands in the Way of the Mainstream Use of the Internet by Pharmaceutical Companies?
- What the Next Generation Physician Wants from Pharma
- What You Need to Know About the New “CAN-SPAM” Law
- What’s Next from the FDA?
- What’s Next vs. What’s Best
- What’s Your Infographics Strategy?
- What’s Your Social Media Implementation Plan?
- When Is Commercial Support Appropriate for CME Activities?
- Who’s Better for Pharma: Obama or McCain?
- Who Owns Your Social Media?
- Whose Data Is It Anyway?
- Why Pharma Can’t Ignore eDetailers
- Why Pharmaceutical Marketers Ignore ROI
- Will COX-2 Inhibitors Crash and Burn?
- Will Critics Kill Pharma’s Social Media Golden Egg Laying Goose? (pdf)
- Will Ethics Revive (Exhume?) the Drug Industry’s Reputation?
- Will Healthcare be Rationed or Rational?: A Case for Supporting Comparative Effectiveness Research
- Will the Drug Industry be the Next Auto Industry?
- Whither CME?
- Whither Twitter for Pharma?
- Without Free Gifts from Pharma to Docs, Would Research be Useless?
- Women in Pharma
- Word-of-Net
Y…
